Response by Resor and Mauri to Letter Regarding Article, “Impact of Optimal Medical Therapy in the Dual Antiplatelet Therapy Study”
This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.
We thank Drs Taqueti and Bhatt for their interest in our article1 and their question regarding proton pump inhibitor (PPI) use in the study. In our subgroup analysis on the impact of optimal medical therapy (OMT) on the treatment effect of continued dual antiplatelet therapy, we observed an unexpected association between use …